Intravenous infusion of umbilical blood cells is a therapeutic procedure used in patients recovering from stroke.
Umbilical cord blood is collected from placenta via the umbilical cord vein.
To achieve an optimum therapeutic effect, a dose of 50 million cells per kg is required, and each infusion includes cord blood collected from 4 to 8 donors.
The entire course of infusions is scheduled over two to three days, and after each infusion, the patient is monitored for several hours for any potential adverse reactions.
In the majority of patients, cord blood infusions have resulted in mild improvement of cognitive and motor functions. These functional gains become noticeable within the first few weeks after the infusion and continue for the next 3 to 6 months.
Adverse reactions to cord blood cell infusions are rare and generally mild.
Ещё видео!